Clinical Trial Update: An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis [Phase 1]

View source ↗

Summary

An early Phase 1 exploratory study to evaluate GC012F injection for refractory generalized myasthenia gravis, with the trial not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Myasthenia Gravis

Drugs mentioned

• GC012F

Snippet

Sponsor: Chongbo Zhao | Conditions: Generalized Myasthenia Gravis (gMG) | Phase 1 | Status: NOT_YET_RECRUITING